US EditionPublished • loading... • Updated
Bank of America Raises Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $32.00
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bank of America Raises Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $32.00
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its target price raised by analysts at Bank of America from $29.00 to $32.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price target points to a potential upside of 12.10% […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
